Young female that may benefit from AKLIEF® (trifarotene) Cream. In clinical trials 55% of the >2000 patients were females

Young Adult Female SALLY, 23 YEARS OLD

Not long after college, Sally suddenly broke out with acne on her cheeks and under her chin. Then her acne spread to her back and shoulders. After seeing a dermatology provider, Sally was prescribed treatment for her face and another for her shoulders and back. She finds it difficult to keep up with their differing instructions.

70% of singles with acne are afraid to date, believing they'll be rejected because of their acne1

AKLIEF® Cream conducted clinical trials where 55% of the >2000 patients were females.2

Teenagers may benefit from AKLIEF® (trifarotene) Cream. In clinical trials 47% of patients were teens 12-17 yrs old


Lucas noticed, after a basketball game, that his acne would flare up on his chest and shoulders. He was embarassed in front of the other boys. While waiting for acne to clear on its own, Lucas' self-esteem began to plummet. His parents were concerned. They understood that without the right treatment, the acne could become more severe.

61% feel they are treated differently by others on days when they have acne flare-ups1

In the AKLIEF® Cream clinical trials, 47% of patients (N=1128) were teens (12-17 years old).3

Pre-teen pediatric female smiling may benefit from AKLIEF® (trifarotene) Cream, indicated for patients 9 years or older

Pediatric AVA, 9 YEARS OLD

Though her friends were understanding and supportive, Ava thought her acne made her look nerdy and felt awkward. As a result, her mother decided the acne should be treated early to avoid it becoming more serious in her teenage years. She scheduled an appointment for Ava with a dermatology provider to help them find the right treatment.

2 family members or close friends with acne on average, are known to most Americans1

AKLIEF® Cream is indicated for patients 9 years or older.4

4 teen girls smiling may benefit from AKLIEF® (trifarotene) Cream. In pivotal studies, 300+ were patients with skin of color

Skin of Color LAUREN, 19 YEARS OLD

Lauren made it through high school without acne becoming an issue. But in college, she began to break out around her cheeks and forehead and blamed it on stress from midterm exams. Despite trying a number of OTC brands, most treatments left her feeling dissatisfied. Lauren just wants an option that is efficacious, and more importantly, tolerable.

Percentage of women affected by clinical acne5:
37% Black/African American
32% Hispanic/Latina
30% Asian
24% Caucasian
23% Continental Indian

AKLIEF® Cream pivotal studies included over 300 skin of color patients.3

Galderma CareConnect patient savings card can help your patients save money on AKLIEF® (trifarotene) Cream prescriptions

Treating acne doesn't have to break the bank.*

Help your patients with acne achieve clearer skin with AKLIEF® (trifarotene) Cream support & savings resources



*Galderma CareConnect is only available for commercially insured and uninsured patients.  Patients who are enrolled in a government-run or government-sponsored healthcare plan with a pharmacy benefit are not eligible to use the Galderma CareConnect Patient Savings Card.


References: 1. Galderma Laboratories L.P. Wakefield Study Leave Behind. USMP/EFO/0106/0520; May 2020. 2. Tan J, Thiboutot D, Popp G, et al. Randomized phase 3 evaluation of trifarotene 50 µg/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol. 2019;80(6):1691-1699. 3. Data on file. Galderma Laboratories L.P. 4. AKLIEF (trifarotene) Cream 0.005% [Prescribing Information]. Ft. Worth, TX: Galderma Laboratories L.P.; October 2019. 5. Callender VD, Alexis AF, Daniels SR, et al. Racial differences in clinical characteristics, perceptions and behaviors, and psychosocial impact of adult female acne. J Clin Aesthet Dermatol. 2014;7(7):19-31.


Indication: AKLIEF® (trifarotene) Cream, 0.005% is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: The most common adverse reactions (incidence ≥ 1%) in patients treated with AKLIEF Cream were application site irritation, application site pruritus (itching), and sunburn. Warnings/Precautions: Patients using AKLIEF Cream may experience erythema, scaling, dryness, and stinging/burning. Use a moisturizer from the initiation of treatment, and, if appropriate, depending upon the severity of these adverse reactions, reduce the frequency of application of AKLIEF Cream, suspend or discontinue use. Avoid application of AKLIEF Cream to cuts, abrasions or eczematous or sunburned skin. Use of “waxing” as a depilatory method should be avoided on skin treated with AKLIEF Cream. Minimize exposure to sunlight and sunlamps. Use sunscreen and protective clothing over treated areas when exposure cannot be avoided.


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

Your use of this website is subject to our Updated Privacy Policy. Click here to read more.